Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Consolidated Net Income: 2018-2021

  • Genmab A's Consolidated Net Income rose 362.62% to $169.09 in Q2 2021 from the same period last year, while for Jun 2021 it was $356.29, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $552.7 million for FY2020, which is 145.38% up from last year.
  • Latest data reveals that Genmab A reported Consolidated Net Income of $169.09 as of Q2 2021, which was up 116.92% from $77.95 recorded in Q4 2020.
  • Genmab A's Consolidated Net Income's 5-year high stood at $25.5 million during Q4 2018, with a 5-year trough of -$11.7 million in Q2 2019.
  • For the 3-year period, Genmab A's Consolidated Net Income averaged around -$2.3 million, with its median value being $72.69 (2019).
  • Per our database at Business Quant, Genmab A's Consolidated Net Income slumped by 100.00% in 2019 and then spiked by 362.62% in 2021.
  • Quarterly analysis of 4 years shows Genmab A's Consolidated Net Income stood at $25.5 million in 2018, then tumbled by 100.00% to $72.69 in 2019, then increased by 7.23% to $77.95 in 2020, then surged by 362.62% to $169.09 in 2021.
  • Its Consolidated Net Income stands at $169.09 for Q2 2021, versus $77.95 for Q4 2020 and $36.55 for Q2 2020.